GRCE Financials

Grace Therapeutics, Inc. - Financial statements & key metrics

Stock Price

$2.15

Market Cap

$34.98M

P/E Ratio

-8.0

EPS

$-0.53

Income Statement Highlights

Most Recent Quarter: 2025-03-31

Revenue

Gross Profit

Operating Income

Net Income

$-9.57M

EPS (Diluted)

$-0.79

Balance Sheet Highlights

Total Assets

$71.99M

Total Liabilities

$5.38M

Shareholders Equity

Cash & Equivalents

$22.13M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-14.90M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-13.2%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is GRCE revenue?

View GRCE's income statement for detailed revenue data.

Is GRCE profitable?

GRCE reported a loss of $9.57M in the most recent quarter.

What is GRCE market cap?

GRCE has a market capitalization of $34.98M, making it a small-cap stock.

Does GRCE have debt?

View GRCE's balance sheet for debt information.

What is GRCE cash flow?

Cash flow data is available in the full financial statements.